This analysis revealed a slight but significant decrease in circulating IGF2 present in the plasma samples derived from PD patients compared to control subjects (p = 0.0185, Fig. 1A), which may be related to the different contributions of tissues and cell types to plasmatic IGF2 levels. Here, IGF2 is linked to Parkinson disease.